Forest Laboratories, Inc. Sees Daxas Response From FDA in Q1 2011
NEW YORK, Sept 13 (Reuters) - Forest Laboratories Inc (FRX.N) said on Monday that it had responded to U.S. Food and Drug Administration concerns about its experimental lung disorder drug and expects to hear from the agency in the first quarter of 2011.